retatrutide updates FDA Approval Status 2026: Everything We Know So Far Retatrutide FDA Approval Status: July

Footnotes: 1) Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci Biotechnol Biochem. 2010;74(3):510-9. doi: 10.1271/bbb.90707. Epub 2010 Mar 7. PMID: 20208358

Obesity is a topic guaranteed to generate discussion since the advent of Social Media, but the more recent launch of effective prescription medications to treat people who are overweight and live with obesity, on and off label, has all the characteristics of a Social Media phenomenon

As more New Zealanders explore medical options for managing obesity, semaglutide has become a widely discussed tool

GLP-1 (glucagon-like peptide-1) is a hormone that regulates insulin and controls appetite, making it crucial for weight management and blood sugar balance

However, sudden visual loss, a new blind area or rapidly worsening eyesight requires emergency evaluation

Aetna may cover Wegovy with prior authorization if you meet BMI and other criteria